PAVmed Inc - Asset Resilience Ratio
PAVmed Inc (PAVM) has an Asset Resilience Ratio of 1.57% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read PAVmed Inc total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how PAVmed Inc's Asset Resilience Ratio has changed over time. See net assets of PAVmed Inc for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down PAVmed Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PAVmed Inc market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $480.00K | 1.57% |
| Total Liquid Assets | $480.00K | 1.57% |
Asset Resilience Insights
- Limited Liquidity: PAVmed Inc maintains only 1.57% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
PAVmed Inc Industry Peers by Asset Resilience Ratio
Compare PAVmed Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for PAVmed Inc (2017–2024)
The table below shows the annual Asset Resilience Ratio data for PAVmed Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 1.13% | $347.00K | $30.66 Million | -6.94pp |
| 2023-12-31 | 8.07% | $2.67 Million | $33.12 Million | +2.50pp |
| 2022-12-31 | 5.57% | $3.00 Million | $53.98 Million | +3.28pp |
| 2021-12-31 | 2.29% | $1.99 Million | $86.98 Million | +0.96pp |
| 2020-12-31 | 1.32% | $262.00K | $19.78 Million | +0.86pp |
| 2019-12-31 | 0.47% | $34.00K | $7.24 Million | -0.05pp |
| 2018-12-31 | 0.52% | $44.25K | $8.50 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $1.64 Million | -- |
About PAVmed Inc
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing… Read more